The success of pharmaceutical companies in developing drugs for treating and curing medical conditions is largely dependent on the quality and completeness of data they gather from clinical trials and ...
Siemens Healthineers AG is holding preliminary talks with several major private equity firms about the potential sale of its diagnostics division for 6 billion euros ($7 billion) and above. This is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback